Market Tracker

12/02 5:16pm ET

Innoviva Inc (NASDAQ:INVA)

10.33
Delayed Data
As of Dec 02
 +0.12 / +1.18%
Today’s Change
7.56
Today|||52-Week Range
14.15
-1.99%
Year-to-Date

Today’s Trading

Previous close10.21
Today’s open10.24
Day’s range10.20 - 10.41
Volume578,735
Average volume (3 months)882,803
Market cap$1.1B
Dividend yield9.69%
Data as of 3:59pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)+89.33%
Earnings growth (this year)+427.50%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+247.57%
P/E ratio29.5
Price/Sales17.94
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AIMTAimmune Therapeutics...+0.24+1.09%
ALDRAlder Biopharmaceuti...+0.20+0.88%
DERMDermira Inc+0.70+2.31%
DEPODepomed Inc+0.39+2.10%
Data as of 3:59pm ET, 12/02/2016

Financials

Next reporting dateFebruary 9, 2017
EPS forecast (this quarter)$0.21
Annual revenue (last year)$67.8M
Annual profit (last year)-$18.8M
Net profit margin-27.68%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Chief Financial Officer &
Senior Vice President
Eric d'Esparbes
Corporate headquarters
South San Francisco, California

Forecasts